Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine
The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNP...
Saved in:
Published in | The international journal of neuropsychopharmacology Vol. 14; no. 1; pp. 83 - 89 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Cambridge, UK
Cambridge University Press
01.02.2011
Oxford University Press |
Subjects | |
Online Access | Get full text |
ISSN | 1461-1457 1469-5111 |
DOI | 10.1017/S1461145710001148 |
Cover
Abstract | The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNPA), which has an agonistic property to dopamine D2 receptors (D2Rs), is expected to bind preferentially to D2,high. The occupancy of dopamine D2Rs by antagonists to receptors has not been investigated using [11C]MNPA. We compared dopamine D2R occupancies by risperidone, an antagonist to receptors, between [11C]MNPA and [11C]raclopride to confirm whether risperidone occupies D2,high and D2,low at almost identical proportions. PET studies were performed on 11 healthy men under resting condition and following oral administration of a single dose of risperidone (0.5–2.0 mg). Striatal receptor occupancy for each radioligand was calculated. The relationship between dose or plasma concentration of risperidone and dopamine D2R occupancy was calculated. Striatal dopamine D2R occupancies measured with [11C]MNPA and [11C]raclopride were 22–65% and 24–69%, respectively. In the striatum, ED50 values measured with [11C]MNPA and [11C]raclopride were 0.98 and 1.03 mg, respectively. The striatal ED50 values as calculated from plasma concentration were 9.15 ng/ml and 8.01 ng/ml, respectively. Almost identical occupancies and ED50 values were observed between the two radioligands, indicating that risperidone bound to D2,high and D2,low at almost identical proportions in a dose-dependent manner. |
---|---|
AbstractList | The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNPA), which has an agonistic property to dopamine D2 receptors (D2Rs), is expected to bind preferentially to D2,high. The occupancy of dopamine D2Rs by antagonists to receptors has not been investigated using [11C]MNPA. We compared dopamine D2R occupancies by risperidone, an antagonist to receptors, between [11C]MNPA and [11C]raclopride to confirm whether risperidone occupies D2,high and D2,low at almost identical proportions. PET studies were performed on 11 healthy men under resting condition and following oral administration of a single dose of risperidone (0.5–2.0 mg). Striatal receptor occupancy for each radioligand was calculated. The relationship between dose or plasma concentration of risperidone and dopamine D2R occupancy was calculated. Striatal dopamine D2R occupancies measured with [11C]MNPA and [11C]raclopride were 22–65% and 24–69%, respectively. In the striatum, ED50 values measured with [11C]MNPA and [11C]raclopride were 0.98 and 1.03 mg, respectively. The striatal ED50 values as calculated from plasma concentration were 9.15 ng/ml and 8.01 ng/ml, respectively. Almost identical occupancies and ED50 values were observed between the two radioligands, indicating that risperidone bound to D2,high and D2,low at almost identical proportions in a dose-dependent manner. The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNPA), which has an agonistic property to dopamine D2 receptors (D2Rs), is expected to bind preferentially to D2,high. The occupancy of dopamine D2Rs by antagonists to receptors has not been investigated using [11C]MNPA. We compared dopamine D2R occupancies by risperidone, an antagonist to receptors, between [11C]MNPA and [11C]raclopride to confirm whether risperidone occupies D2,high and D2,low at almost identical proportions. PET studies were performed on 11 healthy men under resting condition and following oral administration of a single dose of risperidone (0.5a2.0 mg). Striatal receptor occupancy for each radioligand was calculated. The relationship between dose or plasma concentration of risperidone and dopamine D2R occupancy was calculated. Striatal dopamine D2R occupancies measured with [11C]MNPA and [11C]raclopride were 22a65% and 24a69%, respectively. In the striatum, ED50 values measured with [11C]MNPA and [11C]raclopride were 0.98 and 1.03 mg, respectively. The striatal ED50 values as calculated from plasma concentration were 9.15 ng/ml and 8.01 ng/ml, respectively. Almost identical occupancies and ED50 values were observed between the two radioligands, indicating that risperidone bound to D2,high and D2,low at almost identical proportions in a dose-dependent manner. Abstract The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a relationship with psychotic symptoms observed in psychiatric disorders such as schizophrenia. [11C](R)-2-CH3O-N-n-propylnorapomorphine ([11C]MNPA), which has an agonistic property to dopamine D2 receptors (D2Rs), is expected to bind preferentially to D2,high. The occupancy of dopamine D2Rs by antagonists to receptors has not been investigated using [11C]MNPA. We compared dopamine D2R occupancies by risperidone, an antagonist to receptors, between [11C]MNPA and [11C]raclopride to confirm whether risperidone occupies D2,high and D2,low at almost identical proportions. PET studies were performed on 11 healthy men under resting condition and following oral administration of a single dose of risperidone (0.5-2.0 mg). Striatal receptor occupancy for each radioligand was calculated. The relationship between dose or plasma concentration of risperidone and dopamine D2R occupancy was calculated. Striatal dopamine D2R occupancies measured with [11C]MNPA and [11C]raclopride were 22-65% and 24-69%, respectively. In the striatum, ED50 values measured with [11C]MNPA and [11C]raclopride were 0.98 and 1.03 mg, respectively. The striatal ED50 values as calculated from plasma concentration were 9.15 ng/ml and 8.01 ng/ml, respectively. Almost identical occupancies and ED50 values were observed between the two radioligands, indicating that risperidone bound to D2,high and D2,low at almost identical proportions in a dose-dependent manner. [PUBLICATION ABSTRACT] |
Author | Arakawa, Ryosuke Otsuka, Tatsui Suhara, Tetsuya Miyoshi, Michie Takano, Harumasa Okumura, Masaki Halldin, Christer Takahashi, Hidehiko Ito, Hiroshi Nakayama, Kazuhiko Kodaka, Fumitoshi Farde, Lars |
Author_xml | – sequence: 1 givenname: Fumitoshi surname: Kodaka fullname: Kodaka, Fumitoshi organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan – sequence: 2 givenname: Hiroshi surname: Ito fullname: Ito, Hiroshi email: hito@nirs.go.jp organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan – sequence: 3 givenname: Harumasa surname: Takano fullname: Takano, Harumasa organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan – sequence: 4 givenname: Hidehiko surname: Takahashi fullname: Takahashi, Hidehiko organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan – sequence: 5 givenname: Ryosuke surname: Arakawa fullname: Arakawa, Ryosuke organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan – sequence: 6 givenname: Michie surname: Miyoshi fullname: Miyoshi, Michie organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan – sequence: 7 givenname: Masaki surname: Okumura fullname: Okumura, Masaki organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan – sequence: 8 givenname: Tatsui surname: Otsuka fullname: Otsuka, Tatsui organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan – sequence: 9 givenname: Kazuhiko surname: Nakayama fullname: Nakayama, Kazuhiko organization: 2Department of Psychiatry, Jikei University School of Medicine, Tokyo, Japan – sequence: 10 givenname: Christer surname: Halldin fullname: Halldin, Christer organization: 3Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden – sequence: 11 givenname: Lars surname: Farde fullname: Farde, Lars organization: 3Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden – sequence: 12 givenname: Tetsuya surname: Suhara fullname: Suhara, Tetsuya organization: 1Clinical Neuroimaging Team, Molecular Neuroimaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20860881$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkt-K1DAUxoOsuH_0AbyR4F6oYDQnbdLGOxlHV1hc0fVKpKRJOpOlTWrSIvMUvrIZZ1RYWfEqh5Pfd74TvhyjAx-8Reg-0GdAoXr-EUoBUPIKKKW5qG-ho9yShAPAwc8ayPb-EB2ndEUpK3kh7qBDRmtB6xqO0Pdl11k94dDh6NJoozPZAweP1261JqrrnHfTBqdJTXZLmTCqwWXkFcPRajtOIaYXWOH3y8tMzWaDv7lpjdUqeJcm3LuV8gZ_Blh8efzhCWFkcVZckHfEkzGGcdP7ENUYhhDHdR57F93uVJ_svf15gj69Xl4uzsj5xZu3i5fnRBeMAymUNrTtdGWBS2YN7wojZUmN5pRbKpXQrFW0lK0QgqnCUE41E4yZsmppbpygR7u5eYmvs01TM7ikbd8rb8OcGslLwSvJaSYfXiOvwhx9Xq6pgbOiLkuZodOboAKErLmk9ZZ6sKfmdrCmGaMbVNw0v-LIAOwAHUNK0Xa_EaDNNvLmr8izprqm0S6H5YKfonL9P5VPd8owj_9lVOyN1NDmf7Kyfx55s-oHGXfHwQ |
CitedBy_id | crossref_primary_10_1038_jcbfm_2011_201 crossref_primary_10_1002_med_21552 crossref_primary_10_1016_j_clinph_2019_12_405 crossref_primary_10_1016_j_psym_2020_05_013 crossref_primary_10_1016_j_pnpbp_2021_110246 crossref_primary_10_1038_s41386_020_0685_0 crossref_primary_10_1080_15622975_2024_2366235 crossref_primary_10_1097_FTD_0000000000001131 crossref_primary_10_1002_hbm_23844 crossref_primary_10_1007_s00406_023_01711_w crossref_primary_10_1016_j_schres_2019_11_012 crossref_primary_10_1016_j_jaac_2011_10_019 |
ContentType | Journal Article |
Copyright | CINP 2010 CINP 2010 2010 CINP 2010. |
Copyright_xml | – notice: CINP 2010 – notice: CINP 2010 2010 – notice: CINP 2010. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88G 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. M0S M1P M2M PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7TK |
DOI | 10.1017/S1461145710001148 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Proquest Medical Database Psychology Database Proquest Central Premium ProQuest One Academic (New) ProQuest - Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic Neurosciences Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Neurosciences Abstracts |
DatabaseTitleList | Neurosciences Abstracts Publicly Available Content Database Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | F. Kodaka et al. Effect of risperidone on dopamine D2 receptors Thematic Section: New Developments in Schizophrenia Research |
EISSN | 1469-5111 |
EndPage | 89 |
ExternalDocumentID | 2201895541 20860881 10_1017_S1461145710001148 10.1017/S1461145710001148 |
Genre | Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -E. .FH 0E1 0R~ 0VX 123 29J 3V. 4.4 53G 5VS 74X 74Y 7X7 7~V 88E 8AO 8FI 8FJ 8R4 8R5 AAFWJ AAMVS AAOGV AAPPN AAPXW AAVAP ABITZ ABIVO ABKKG ABMYL ABPTD ABQLI ABUWG ABXVV ACGFS ACIMK ADBBV ADHZD ADRAZ AEMTW AENEX AENZO AFFVI AFKRA AFPKN AFULF AFUTZ AHMBA AJ7 ALMA_UNASSIGNED_HOLDINGS ALUQC AOIJS ARABE AVWKF AZQEC BAWUL BAYMD BCNDV BENPR BPHCQ BTTYL BVXVI C0O CAG CCPQU CIDKT COF CS3 DC4 DIK DU5 DWQXO EBS EJD EMOBN FYUFA GNUQQ GROUPED_DOAJ HG- HMCUK HST HYE HZ~ I.6 IAO IHR I~P J36 J38 J3A KQ8 KSI L98 LW7 M-V M1P M2M M48 ML0 M~E O9- OAWHX OJQWA OJZSN OK1 P2P PEELM PQQKQ PROAC PSQYO PSYQQ Q2X RHF RIG ROL ROX RPM RR0 S6- S70 TJX TOX TUQ UKHRP UU6 WQ3 WXU WXY WYP ABEJV ABGNP ABVKB ALIPV AMNDL H13 PIMPY AAYXX CITATION ITC PHGZM PHGZT CGR CUY CVF ECM EIF NPM PJZUB PPXIY 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7TK PUEGO |
ID | FETCH-LOGICAL-c3251-3acd0bfc7e1592ed5f3d9940dc505e09a6c2ba049b6662a3d050c2622d47b02a3 |
IEDL.DBID | M48 |
ISSN | 1461-1457 |
IngestDate | Thu Sep 04 20:11:44 EDT 2025 Sat Jul 26 01:08:56 EDT 2025 Fri Jul 25 21:52:26 EDT 2025 Mon Jul 21 06:05:28 EDT 2025 Tue Jul 01 01:04:04 EDT 2025 Thu Apr 24 23:00:13 EDT 2025 Tue Feb 04 08:58:36 EST 2025 Wed Mar 13 05:46:35 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | receptor occupancy Binding potential [11C]MNPA dopamine D2 receptor risperidone receptor dopamine D [ C]MNPA |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3251-3acd0bfc7e1592ed5f3d9940dc505e09a6c2ba049b6662a3d050c2622d47b02a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3169859089?pq-origsite=%requestingapplication%&accountid=15518 |
PMID | 20860881 |
PQID | 3169859089 |
PQPubID | 43629 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_954657950 proquest_journals_815238449 proquest_journals_3169859089 pubmed_primary_20860881 crossref_primary_10_1017_S1461145710001148 crossref_citationtrail_10_1017_S1461145710001148 oup_primary_10_1017_S1461145710001148 cambridge_journals_10_1017_S1461145710001148 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20110200 20110201 2011-2-00 2011-Feb |
PublicationDateYYYYMMDD | 2011-02-01 |
PublicationDate_xml | – month: 02 year: 2011 text: 20110200 |
PublicationDecade | 2010 |
PublicationPlace | Cambridge, UK |
PublicationPlace_xml | – name: Cambridge, UK – name: England – name: Oxford |
PublicationTitle | The international journal of neuropsychopharmacology |
PublicationTitleAlternate | Int J Neuropsychopharmacol |
PublicationYear | 2011 |
Publisher | Cambridge University Press Oxford University Press |
Publisher_xml | – name: Cambridge University Press – name: Oxford University Press |
SSID | ssj0024536 |
Score | 1.9196906 |
Snippet | The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity, implying a... Abstract The increased proportion of the high-affinity state of dopamine D2/3 receptors (D2,high) is assumed to correlate with dopamine hypersensitivity,... |
SourceID | proquest pubmed crossref oup cambridge |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 83 |
SubjectTerms | Adult Apomorphine - analogs & derivatives Apomorphine - metabolism Brain - diagnostic imaging Brain - drug effects Brain - metabolism Dopamine Dopamine Agonists - metabolism Dopamine Antagonists - blood Dopamine Antagonists - metabolism Dopamine Antagonists - pharmacology Dopamine D2 Receptor Antagonists Humans Ligands Magnetic Resonance Imaging Male Positron-Emission Tomography Raclopride - metabolism Radiopharmaceuticals - metabolism Receptors, Dopamine D2 - agonists Receptors, Dopamine D2 - metabolism Risperidone - blood Risperidone - metabolism Risperidone - pharmacology Schizophrenia - diagnostic imaging Schizophrenia - metabolism Young Adult |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1baxNBFB5q--KLeDe2ynnQopLB2Z2dvQgiGlOCYAwlhYJImNuWQrq7mvYhv8K_7Dl7yVICwdeZ2ctwzpn55nK-j7FXmbA6Ucpyp5znkbWSp7nwXMswR7gdaGcoG_n7NJ6cRd_O1fkem3a5MHStshsT64HalZb2yN_LIM5SEujOPlW_OalG0elqJ6GhW2kF97GmGLvDDnBITtHvD76Mp7PTnn1PyTbfKOBBpJLunJNIpKmQyoIaJ5EgUM-2cGvWupUJtwVI64np5D671yJK-Ny4wAO254uH7HjWUFKvhzDvM6xWQziGWU9WvX7E_jb0xVDmgOFOtMeuLDyUBRCRMdd5folBv4Y68YhaOVxlXyE0ha8h4GjpK5Lr-QAaZuM51GS1QHu7oC9KIuWF5eWFLhz8DILRrzenb3nIRxP5g095wbFr1XpZoBNW5VWJBsfXPmZnJ-P5aMJbkQZuJdqSS22dMLlNPAKj0DuVS5dlkXAWsZUXmY5taDSuQwwulEItnVDChnEYuigxAguesP0CO_aMgcq9j41ziDE9tU91KoPcZSZKI2mEGbDhxiCLNtRWi-aaWrLYst-Aic5mC9sSnpPuxnLXI-82j1QN28euxq_REf6n3VHnKv1f9-48YIfb1SnCKplGEdbCphYDn05zdOHLm9UiIxn7JFNiwJ42_rf5lRDXqTh7BM93f_mQ3W12yOlyzhHbv_5z418gxLo2L9u4-QejjxxM priority: 102 providerName: ProQuest |
Title | Effect of risperidone on high-affinity state of dopamine D2 receptors: a PET study with agonist ligand [11C](R)-2-CH3O-N-n-propylnorapomorphine |
URI | https://www.cambridge.org/core/product/identifier/S1461145710001148/type/journal_article https://www.ncbi.nlm.nih.gov/pubmed/20860881 https://www.proquest.com/docview/3169859089 https://www.proquest.com/docview/815238449 https://www.proquest.com/docview/954657950 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZaxsxEBY5XvpSetdNavTQhrZYrVbHHoVSWtfBFOKa1AZDCYuuDQFn140T6P6K_uWO9rAbHEJeVyOh3ZlZfSNpvkHoVUKNiqQ0xErriDCGkzijjijOMoDbgbLaZyMfjcLhVHyfydkWastbNR9weWNo5-tJTS_m7__8Lj-Dw39qWII-_PS1qQMhPVFNhe-30S4sTKGPxY5EvKbek7xJNgqIF28POW8a4n-qhWtL1rU0uA00Wq1Khw_Q_QZO4i-1_h-iLZc_Qgfjmo-67OHJOr1q2cMHeLxmqi4fo781dzEuMgy-7jmPbZE7XOTYsxgTlWVn4PElrrKOvJSFEPsccCn-xjD8Kt3C1-r5iBUeDya4YqrFfmMXq9PCM_Li-dmpyi3-FQT9kzfHbwkj_SH_QUYkJ_Bqi3KegwUuivMCtA3DPkHTw8GkPyRNhQZiOCiScGUs1ZmJHKAi5qzMuE0SQa0BYOVookLDtIIgREOUxBS3VFLDQsasiDSFB0_RTg4v9hxhmTkXamsBYDovH6uYB5lNtIgF11R3UG-lkLQ1k7S-oxalG_rrINrqLDUN27kvujG_rcu7VZdFTfVxm_BrMIS7yO23prKeNQ_CJPbF5pMO2ttsjgFT8VgIaMWrVvB6f5SjcldcLdPE17CPEkk76Fltf6upMAhSYekIXtxxhnvoXr1P7q_o7KOdy4sr9xKA1qXuou1oFnXR7tfBaHzcrZzpH1TTG8c |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxQxFA51-6Av4t21VfNgi8oGM7nMRSii2y1b265L2UKhyJhJMqWwnVndFplf4T_yt3kylx3KwuJLX3OZSTiXfLmc7yD0JqJaBVJqYqSxRGjNSZhSSxRnKcBtT5nERSMfjfzhifh6Kk_X0N8mFsY9q2x8YumoTa7dGfkH7vlR6BJ0R59mP4nLGuVuV5sUGqpOrWB2SoqxOrDjwBa_YQs339nfBXlvMbY3mPSHpM4yQDSHwRCutKFJqgMLKzuzRqbcRJGgRgM4sDRSvmaJAiCdANJnihsqqWY-Y0YECYUC-O4dtC5chGsHrX8ZjMbHLduf5HV8k0c8IYPmXtWRVrtCV-aVuMwlIGrZHW6skjci75YAcLkQ7j1A92sEiz9XKvcQrdnsEdoeVxTYRQ9P2oiueQ9v43FLjl08Rn8qumScpxjci6NZNnlmcZ5hR5xMVJpegJMpcBno5FoZ2NVfAhTGuwyDd7Yzlx7oI1Z4PJjgkhwXu7NkrM5zRwKMpxfnKjP4zPP6398evyOM9If8GxmRjMDUZsU0A6Wf5Zc5KBh89gk6uRVxPUWdDCb2HGGZWusnxgCmta59qELupSZKRCh4QpMu6i0EEtemPY-rZ3FBvCS_LqKNzGJdE6y7PB_TVV3eL7rMKnaRVY23QBH-p91moyrtqFvz6aKN5eoQYBwPhYBavKgFR-Nuj1Rm8-t5HEnhyyCStIueVfq3GAqDfTGsVt6L1X9-je4OJ0eH8eH-6GAD3atO593DoE3Uufp1bV8CvLtKXtU2hNGP2zbbf7VcWJU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+risperidone+on+high-affinity+state+of+dopamine+D2+receptors%3A+a+PET+study+with+agonist+ligand+%5B11C%5D%28R%29-2-CH3O-N-n-propylnorapomorphine&rft.jtitle=The+international+journal+of+neuropsychopharmacology&rft.au=Kodaka%2C+Fumitoshi&rft.au=Ito%2C+Hiroshi&rft.au=Takano%2C+Harumasa&rft.au=Takahashi%2C+Hidehiko&rft.date=2011-02-01&rft.pub=Cambridge+University+Press&rft.issn=1461-1457&rft.eissn=1469-5111&rft.volume=14&rft.issue=1&rft.spage=83&rft.epage=89&rft_id=info:doi/10.1017%2FS1461145710001148&rft.externalDocID=10.1017%2FS1461145710001148 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1461-1457&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1461-1457&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1461-1457&client=summon |